Insurance prices of innovative drugs in Korea are more expensive than advanced countries

Published: 2002-09-30 06:58:00

Updated: 2002-09-30 06:58:00

The domestic insurance price of some innovative drugs, being more superior to the existing drugs in terms of efficacy and toxicity, is higher than foreign counterparts, a lawmaker said on September 25.

During the recent parliamentary inspection to the Health Insurance Review Agency (HIRA), Rep...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK